(3-fluoro-phenyl)-phenylamino-acetic acid | 1104895-97-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (3-fluoro-phenyl)-phenylamino-acetic acid
• 英文别名: 2-anilino-2-(3-fluorophenyl)acetic acid
• CAS: 1104895-97-7
• 化学式: C₁₄H₁₂FNO₂
• mdl: MFCD10037233
• 分子量: 245.253
• InChiKey: QPDRRXPGPIBRDX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.071
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  二氧化碳 、 3-fluorobenzylideneaniline 以 N,N-二甲基甲酰胺 为溶剂， 以85%的产率得到(3-fluoro-phenyl)-phenylamino-acetic acid
  参考文献：
  名称：

  Electrochemical carboxylation of fluorocontaining imines with preparation of fluorinated N-phenylphenylglycines

  摘要：

  A possibility of obtaining fluorine-containing N-phenylphenylglycine derivatives at yields of up to 85% via the electrochemical carboxylation of corresponding benzalanilines was shown. The influence of imine's electron structure, the nature of supporting electrolyte and cathodic material on such processes is examined. It was found, that increasing electron accepting ability of the substituents in benzylidene and aniline fragments of the imine molecule lead to decrease of amino acid yields. The dependence of the N-phenyl-p-fluorophenylglycine yield on the cathode material (Zn, GC, Cu, Ag, Pt) and on the nature of the supporting electrolytes (Bu4NBr, Et4NBr, Et4NClO4, PhCH2Me3NClO4, LiBF4, LiClO4, NaBF4 and KBF4) Was investigated. The highest amino acid yields were obtained at cathodes (GC and Zn) that do not exhibit specific adsorption of fluorine-containing imines, as well as in the presence of background salts (Alk(4)NBr) whose cations do not show tendency to strong ion pairing with anion radicals formed by the electrochemical activation of the imines. (c) 2008 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.jfluchem.2008.06.010

文献信息

• ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF
  申请人：AMARI Gabriele

  公开号：US20110311459A1

  公开（公告）日：2011-12-22

  The present invention relates to alkaloid aminoester compounds which act as muscarinic receptor antagonists, processes for the preparation of such a compound, compositions which contain such a compound, and therapeutic uses of such a compound.

  本发明涉及作为毒蕈碱受体拮抗剂的生物碱氨基酯化合物，制备此类化合物的方法，含有此类化合物的组合物，以及此类化合物的治疗用途。
• [EN] ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF<br/>[FR] DÉRIVÉS AMINOESTÉRIFIÉS D'ALCALOÏDES ET COMPOSITION MÉDICINALE LES INCLUANT
  申请人：CHIESI FARMA SPA

  公开号：WO2010072338A1

  公开（公告）日：2010-07-01

  The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, to methods of preparing such derivatives, to compositions comprising them and therapeutic use thereof.

  本发明涉及作为毒蕈碱受体拮抗剂的生物碱氨基酸酯衍生物，制备此类衍生物的方法，包含它们的组合物以及它们的治疗用途。
• Alkaloid aminoester derivatives and medicinal composition thereof
  申请人：Caligiuri Antonio

  公开号：US08455646B2

  公开（公告）日：2013-06-04

  Alkaloid aminoester compounds which act as muscarinic receptor antagonists are useful for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.

  生物碱氨酯化合物可作为肌动蛋白受体拮抗剂，对预防和/或治疗支气管阻塞性或炎症性疾病有用。
• Alkaloid aminoester derivatives and medicinal compositions thereof
  申请人：Chiesi Farmaceutici S.p.A.

  公开号：EP2585458B1

  公开（公告）日：2015-01-07
• US5374656A
  申请人：——

  公开号：US5374656A

  公开（公告）日：1994-12-20